WRAD Brings One Voice for Radiotherapy to China

WRAD travelled to Changsha City, Hunan Province, China for the 2026 Chinese Congress on Holistic Integrative Oncology (CCHIO), organised by the Chinese Anti-Cancer Association (CACA) and Hunan Cancer Hospital. Representing over 110 professional organisations and over 800,000 members, CACA plays a leading role in advancing cancer education, research, clinical guidelines and international collaboration.
The CACA-WRAD Summit opened with a powerful address from session chair Professor Chao-nan Qian, Guangzhou Concord Cancer Center, emphasising the essential role of radiotherapy in cancer care. With approximately half of all cancer patients requiring radiotherapy, achieving equitable access demands sustained investment in infrastructure, services and innovation.

We were told that the proportion of cancer patients receiving radiotherapy in China is currently about 30%, highlighting the need to improve access rates.

WRAD Co-Chairs Sandra Turner and Katie Wakeham joined Dr Nan Bi, Chinese Academy of Medical Sciences and Peking Union Medical College, and Dr Feng Liu, Hunan Cancer Centre, to explore the power of advocacy in raising public and policymaker awareness, strengthening access to radiotherapy and driving investment in cancer services.
The Summit also celebrated the launch of WRADdy, the WRAD plushie, which proved a great success in bringing radiotherapy awareness to life. Over 200 delegates signed up to join WRAD, demonstrating growing enthusiasm for the global campaign.
WRAD’s vision was also shared with international organisations, including SIOG, London Global Cancer Week and UICC during the congress.

The CACA-WRAD collaboration marked an important milestone in extending WRAD’s global reach, bringing One Voice for Radiotherapy to China and strengthening international partnerships to improve access to life-saving radiotherapy.



